Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Post by TOCATon Sep 24, 2013 11:24am

240 Views

Post# 21763175

Dr. Shapiro speaks Sept 26, 2013

will he release data on the cell pouch and will this information shock the IPITA conference. At least we may have some clinical data on the cell pouch if it is part of his speach. It may go unnoticed at this large conference but it could also gather interest. Dr. Philip Toleikis and Dr. James Shapiro could be inundated with queries and requests.

Bullboard Posts

How a junior advances one of the largest undeveloped diamond projects